Retevmo 120 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FJU44
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,358
Award facts
- Contract value 100% obligated
- $15,358.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,358.24 to AmerisourceBergen Drug Corp for RETEVMO 120 mg tablets (60-count supply) on September 5, 2025, with an ultimate completion date of September 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting Department of Defense and veteran healthcare systems. The company's role as a prime vendor under the DLA Troop Support Medical contract demonstrates its capability to supply a diverse portfolio of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains. This delivery order for RETEVMO, a specialized pharmaceutical product, exemplifies the company's ongoing support of military and federal healthcare procurement requirements through competitively awarded contracts with consistent firm fixed-price terms.
Quick answers
Who was awarded contract SPE2DB25FJU44?
SPE2DB25FJU44 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FJU44 worth?
The government has obligated $15,358 on SPE2DB25FJU44.
Is contract SPE2DB25FJU44 an order under another contract?
Yes. SPE2DB25FJU44 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJU44 competed?
The extent of competition for SPE2DB25FJU44 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award